220 related articles for article (PubMed ID: 11132770)
1. Cytokine profiles in early rejection following OKT3 treatment in liver transplant patients.
Roayaie S; Sheiner PA; Emre S; Guy S; Schwartz ME; Boros P; Miller CM
Mediators Inflamm; 2000; 9(3-4):141-6. PubMed ID: 11132770
[TBL] [Abstract][Full Text] [Related]
2. Th1/Th2 cytokines and ICAM-1 levels post-liver transplant do not predict early rejection.
Granot E; Tarcsafalvi A; Emre S; Sheiner P; Guy S; Schwartz ME; Boros P; Miller CM
Mediators Inflamm; 2000; 9(1):35-8. PubMed ID: 10877453
[TBL] [Abstract][Full Text] [Related]
3. Mouse antibody-coated lymphocytes during OKT3 therapy in liver transplantation.
Broughan TA; Valenzuela R; Escorcia E; Secic M; Vogt DP
Clin Transplant; 1994 Oct; 8(5):488-91. PubMed ID: 7819617
[TBL] [Abstract][Full Text] [Related]
4. Acute lung transplant rejection is associated with localized increase in T-cell IFNgamma and TNFalpha proinflammatory cytokines in the airways.
Hodge G; Hodge S; Chambers D; Reynolds PN; Holmes M
Transplantation; 2007 Dec; 84(11):1452-8. PubMed ID: 18091521
[TBL] [Abstract][Full Text] [Related]
5. Serum T-lymphocyte cytokines cannot predict early acute rejection in renal transplantation.
Ghafari A; Makhdoomi K; Ahmadpour P; Afshari AT; Lak SS; Fakhri L
Transplant Proc; 2007 May; 39(4):958-61. PubMed ID: 17524862
[TBL] [Abstract][Full Text] [Related]
6. Increased dermal expression of ICAM-1 and VCAM-1 after administration of OKT3 in man.
Buysmann S; van Diepen FN; Surachno S; Pals ST; ten Berge RJ
Clin Nephrol; 1996 Aug; 46(2):84-91. PubMed ID: 8869784
[TBL] [Abstract][Full Text] [Related]
7. A non-activating "humanized" anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo.
Alegre ML; Peterson LJ; Xu D; Sattar HA; Jeyarajah DR; Kowalkowski K; Thistlethwaite JR; Zivin RA; Jolliffe L; Bluestone JA
Transplantation; 1994 Jun; 57(11):1537-43. PubMed ID: 8009586
[TBL] [Abstract][Full Text] [Related]
8. Cytokines and transplantation: a clinical perspective.
Gaston RS
Transplant Sci; 1994 Dec; 4 Suppl 1():S9-19. PubMed ID: 7627452
[TBL] [Abstract][Full Text] [Related]
9. Induction of an acute phase response after OKT3 therapy.
Pohanka E; Kovarik J; Klauser R; Woloszcsuk W; Zlabinger GJ
Transplant Proc; 1992 Feb; 24(1):269-70. PubMed ID: 1371618
[No Abstract] [Full Text] [Related]
10. Sparing of first dose effect of monovalent anti-CD3 antibody used in allograft rejection is associated with diminished release of pro-inflammatory cytokines.
Abbs IC; Clark M; Waldmann H; Chatenoud L; Koffman CG; Sacks SH
Ther Immunol; 1994 Dec; 1(6):325-31. PubMed ID: 7584508
[TBL] [Abstract][Full Text] [Related]
11. Cytokine gene polymorphisms and acute human liver graft rejection.
Warlé MC; Farhan A; Metselaar HJ; Hop WC; Perrey C; Zondervan PE; Kap M; de Rave S; Kwekkeboom J; Ijzermans JN; Tilanus HW; Pravica V; Hutchinson IV; Bouma GJ
Liver Transpl; 2002 Jul; 8(7):603-11. PubMed ID: 12089714
[TBL] [Abstract][Full Text] [Related]
12. The effect of rabbit antithymocyte serum (RATS) and OKT3 on peripheral blood mononuclear cell subsets following renal transplantation.
Zaltzman JS; Cole EH; Freedman J
Clin Transplant; 1994 Dec; 8(6):516-22. PubMed ID: 7865912
[TBL] [Abstract][Full Text] [Related]
13. Regional cytokine changes following OKT3 induction for islet cell transplantation in humans: early increase in portal and systemic levels of interleukin-6 and tumor necrosis factors.
Burke GW; Alejandro R; Cirocco R; Nery J; Mintz D; Miller J
Transplant Proc; 1992 Jun; 24(3):962-4. PubMed ID: 1604687
[No Abstract] [Full Text] [Related]
14. Increased risk of early rejection correlates with recovery of CD3 cell count after liver transplant in patients receiving OKT3 induction.
Sheiner PA; Guarrera JV; Grunstein E; Emre S; Guy SR; Schwartz ME; Miller CM; Boros P
Transplantation; 1997 Oct; 64(8):1214-6. PubMed ID: 9355846
[TBL] [Abstract][Full Text] [Related]
15. [Serum cytokine profiles in stable survivors with clinical liver transplantation].
Wan YL; Zheng SS; Wei JF; Jia CK; Hu ZR
Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(4):207-9. PubMed ID: 15062036
[TBL] [Abstract][Full Text] [Related]
16. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
Huang WH; Yan Y; De Boer B; Bishop GA; House AK
Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
[TBL] [Abstract][Full Text] [Related]
17. Use of daclizumab as initial immunosuppression in liver transplant recipients with impaired renal function.
Emre S; Gondolesi G; Polat K; Ben-Haim M; Artis T; Fishbein TM; Sheiner PA; Kim-Schluger L; Schwartz ME; Miller CM
Liver Transpl; 2001 Mar; 7(3):220-5. PubMed ID: 11244163
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of cytokine determination for screening, differentiation, and therapy monitoring of infectious and noninfectious complications after orthotopic liver transplantation.
Kraus T; Noronha IL; Manner M; Klar E; Küppers P; Otto G
Transplant Proc; 1991 Feb; 23(1 Pt 2):1509-12. PubMed ID: 1824900
[No Abstract] [Full Text] [Related]
19. Acute liver transplant rejection upon immunosuppression withdrawal in a tolerance induction trial: potential role of IFN-gamma-secreting CD8+ T cells.
Donckier V; Craciun L; Lucidi V; Buggenhout A; Troisi R; Rogiers X; Boon N; Gustot T; Moreno C; Bourgeois N; Colle I; Van Vlierberghe H; Nagy N; Praet M; Dernies T; Amrani M; Stordeur P; de Hemptinne B; Goldman M
Transplantation; 2009 May; 87(9 Suppl):S91-5. PubMed ID: 19424019
[TBL] [Abstract][Full Text] [Related]
20. Common and sequential overexpression patterns of T-helper cytokines during acute (cellular) rejection, and correlation of proinflammatory cytokine expression with chronic (ductopenic) rejection of human liver allografts: a study under cyclosporine, FK 506, and quadruple BT 563 immunosuppression.
Gaweco AS; Otto G; Otto HF; Meuer S; Geisse T; Hofmann WJ
Transplant Proc; 1995 Feb; 27(1):1152-4. PubMed ID: 7533370
[No Abstract] [Full Text] [Related]
[Next] [New Search]
